三种成人声门上气道装置术后咽喉痛比较:随机对照试验
在546例全麻下择期短小手术患者中,比较LMA-Unique、LMA-Supreme与I-gel三种声门上气道装置术后24小时咽喉痛发生率。主要终点在436例中评估,总咽喉痛发生率为23.9%,三组间无显著差异(P=0.34)。LMA-Supreme组液体吞咽困难发生率较高(P=0.0065),I-gel插入时间较短(P<0.0167)。
要点
- 三种声门上气道装置术后24小时咽喉痛发生率无显著差异(23.9%,P=0.34)。
- LMA-Supreme组液体吞咽困难发生率(12.1%)高于LMA-Unique(5.3%)和I-gel(2.9%)。
- I-gel插入时间较短(30秒)且气道漏气压较高(26 cmH2O)。
核心结论
- 三种声门上气道装置(LMA-Unique、LMA-Supreme、I-gel)术后24小时咽喉痛发生率无显著差异。
研究设计与样本
- 随机单盲三组平行对照试验,纳入546例全麻下择期短于2小时手术的成人患者,随机分配至LMA-Unique、LMA-Supreme或I-gel组。
主要发现
- 主要终点在436例中评估,104例(23.9%)报告术后24小时咽喉痛,组间无差异(P=0.34)。
- LMA-Supreme组液体吞咽困难发生率12.1%,高于LMA-Unique组5.3%和I-gel组2.9%(P=0.0065)。
- LMA-Unique组气道漏气压21(18-27)cmH2O,低于I-gel组26(20-30)cmH2O和LMA-Supreme组25(21-30)cmH2O(P<0.0001)。
- I-gel组插入时间30(20-40)秒,短于LMA-Unique组34(23-48)秒和LMA-Supreme组32(22-50)秒(P<0.0167)。
临床怎么用
- 选择声门上气道装置时,三种装置术后咽喉痛风险相当,可结合插入时间和气道密封性等性能特点个体化选用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sore throat is a common complaint after surgery. It affects patient satisfaction and can affect activity after discharge. The supraglottic airway device (SAD) offers an alternative to traditional tracheal intubation with potential benefit in preventing sore throat. OBJECTIVE: The aim of this study was to compare the incidence of sore throat following three different SADs, the laryngeal mask airway Unique (LMA-U) and the more recent LMA Supreme (LMA-S) and the I-gel. DESIGN: A randomised single-blind controlled three parallel-group trial. SETTING: University Hospital of Nîmes, Division of Anaesthesia Intensive Care Pain and Emergency, Nîmes, France, from April 2009 to September 2012. PATIENTS: A total of 546 patients scheduled to undergo elective surgery of less than 2 h under general anaesthesia were randomly allocated to receive the LMA-U, the LMA-S or the I-gel. INTERVENTIONS: Anaesthesia was induced with propofol and sufentanil and maintained with propofol or with sevoflurane in air-oxygen. After airway device insertion, intra-cuff pressure was adjusted to less than 60 mmHg (LMA-U, LMA-S) and pressure-controlled ventilation initiated. MAIN OUTCOMES: The primary study endpoint was to compare incidence of sore throat 24 h postoperatively (H+24) following placement of the LMA-U, LMA-S and the I-gel. Secondary endpoints were clinical performance (airway leak pressure, dynamic airway compliance, complications during maintenance), ease of use (device insertion time, success on first attempt, ease of insertion and removal) and other adverse events (neck or jaw pain, dysphonia, dysphagia, nausea and vomiting). RESULTS: The authors analysed 177, 174 and 173 patients who received LMA-U, the LMA-S and the I-gel, respectively. The primary endpoint was assessed in 436 patients. In total, 104 patients (23.9%) patients reported a H+24 sore throat, with no difference between groups (P = 0.34). H+24 dysphagia with liquids was higher (P = 0.0065) with the LMA-S (12.1%) compared with LMA-U (5.3%) and I-gel (2.9%). Airway leak pressure (cmH2O) was lower (P < 0.0001) with LMA-U [21 (18 to 27)] compared with I-gel [26 (20 to 30)] and LMA-S [25 (21 to 30)]. Device insertion time (sec) was shorter (P < 0.0167) with the I-gel [30 (20 to 40)] compared with the LMA-U [34 (23 to 48)] and LMA-S [32 (22 to 50)]. CONCLUSION: The incidence of postoperative sore throat was not significantly different between the three SADs studied.
引用
- L'Hermite J, Dubout E, Bouvet S, et al. Sore throat following three adult supraglottic airway devices: A randomised controlled trial. Eur J Anaesthesiol. 2017. PMID: 27755181. doi:10.1097/EJA.0000000000000539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。